Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

, ESRX

Express Scripts

$70.57

0.51 (0.73%)

08:57
10/11/16
10/11
08:57
10/11/16
08:57

Horizon Pharma sees FY16 adjusted net sales at low end of $1.02B-$1.05B

Consensus $1.03B. Horizon Pharma (HZNP) is providing estimates of certain Q3 results, confirming expected net sales on a non-GAAP adjusted basis at the low end of its previously announced full-year net sales guidance range and revising its full-year 2016 adjusted EBITDA guidance range, reflecting higher fourth-quarter investment spending. The additional operating expenses reflect strategic investments the company is making to support future growth opportunities, particularly as it transitions its business mix toward orphan disease medicines and builds a more durable primary care business, Horizon stated in a regulatory filing. The company anticipates, on a GAAP basis including the previously announced $65M settlement with Express Scripts (ESRX) as a one-time reduction in GAAP net sales, its full-year 2016 net sales will be approximately $960M. Excluding the $65M settlement, the company now expects that net sales on a non-GAAP adjusted basis will be at the low end of its previously announced full-year net sales guidance range of $1.025B-$1.05B, or approximately $1.025B. The exclusion of the $65M settlement from GAAP net sales guidance is the only adjustment reflected in Horizon Pharma's full-year 2016 non-GAAP adjusted net sales guidance. The company is revising its full-year 2016 adjusted EBITDA guidance range as the result of expected net sales at the low end of its non-GAAP adjusted net sales guidance range and anticipated higher investment spending in the fourth quarter of 2016 and now expects adjusted EBITDA to be in the range of $450M-$460M, prior range was $495M-$510M. The company's full-year 2016 guidance does not include the previously announced expected acquisition of Raptor Pharmaceutical Corp.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

ESRX

Express Scripts

$70.57

0.51 (0.73%)

  • 26

    Oct

  • 06

    Nov

  • 14

    Dec

HZNP Horizon Pharma
$19.52

0.79 (4.22%)

08/02/16
BMOC
08/02/16
NO CHANGE
BMOC
Outperform
Horizon Pharma scored 'important win' with CVS, says BMO Capital
BMO Capital analyst Gary Nachman said Horizon Pharma (HZNP) securing covered status for Duexis and Vimovo with CVS/Caremark (CVS) is an "important win" for the drugmaker that demonstrates it is improving its execution on the managed care front. While Express Scripts (ESRX) still has Duexis and Vimovo on its exclusion list for 2017, Horizon indicated that it is still in discussions that have been "constructive," noted Nachman, who keeps an Outperform rating on Horizon shares.
09/13/16
BMUR
09/13/16
NO CHANGE
Target $32
BMUR
Buy
Horizon Pharma acquisition a positive, says Brean Capital
Brean Capital analyst Difei Yang said she is positive on Horizon Pharma's (HZNP) deal for Raptor Pharmaceuticals (RPTP). The analyst cited Horizon executing on its transformative strategy into an orphan disease company, the reasonable price paid for the company, and the moderate growth opportunities for synergies between the two. Yang reiterated her Buy rating and raised her price target to $32 from $30 on Horizon Pharma shares.
09/30/16
JMPS
09/30/16
NO CHANGE
JMPS
Horizon Pharma patent loss immaterial, says JMP Securities
After the U.S. Patent and Trademark Office ruled that Horizon Pharma's '215 patent for Ravicti is unpatentable, JMP Securities analyst Donald Ellis says the news is not material. He says that Ravicti still has orphan drug exclusivity until 2020, and that the company has five other patents on the drug that will last until 2032. He recommends buying Horizon on any weakness.
10/03/16
BMOC
10/03/16
NO CHANGE
BMOC
Horizon Pharma added to US Small Cap Fundamental List at BMO Capital
ESRX Express Scripts
$70.57

0.51 (0.73%)

08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.
10/05/16
UBSW
10/05/16
INITIATION
Target $76
UBSW
Neutral
Express Scripts initiated with a Neutral at UBS
Target $76.

TODAY'S FREE FLY STORIES

INTC

Intel

$43.14

-0.1 (-0.23%)

, AMD

AMD

$11.91

-0.11 (-0.92%)

16:26
01/16/18
01/16
16:26
01/16/18
16:26
Hot Stocks
Rep. McNerney requests briefing from Intel, AMD on security vulnerabilities »

U.S. Representative from…

INTC

Intel

$43.14

-0.1 (-0.23%)

AMD

AMD

$11.91

-0.11 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 30

    Jan

AMGP

Antero Midstream GP

$21.00

-0.04 (-0.19%)

16:22
01/16/18
01/16
16:22
01/16/18
16:22
Hot Stocks
Antero Midstream GP increases dividend 27% to 7.5c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AM

Antero Midstream Partners

16:21
01/16/18
01/16
16:21
01/16/18
16:21
Hot Stocks
Antero Midstream Partners increases dividend 7% to 36.5c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

ESP

Espey Mfg

$24.55

-0.1092 (-0.44%)

16:21
01/16/18
01/16
16:21
01/16/18
16:21
Hot Stocks
Espey Mfg announces new three-year term for CEO Patrick Enright, Jr. »

Espey Mfg. &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTM

Quantum

$6.07

-0.07 (-1.14%)

, GUID

Guidance Software

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Hot Stocks
Quantum appoints Patrick Dennis as CEO »

Quantum (QTM) announced…

QTM

Quantum

$6.07

-0.07 (-1.14%)

GUID

Guidance Software

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
01/16/18
01/16
16:20
01/16/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$335.16

-1.05 (-0.31%)

, ADNT

Adient

$82.18

-0.51 (-0.62%)

16:19
01/16/18
01/16
16:19
01/16/18
16:19
Hot Stocks
Boeing, Adient launch new company to design, build airplane seats »

Boeing (BA) and Adient…

BA

Boeing

$335.16

-1.05 (-0.31%)

ADNT

Adient

$82.18

-0.51 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 29

    Jan

  • 31

    Jan

  • 21

    Feb

CLD

Cloud Peak

$5.31

-0.24 (-4.32%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Cloud Peak Energy signs long-term coal export pact with JERA Trading »

Cloud Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

GDEN

Golden Entertainment

$31.70

-0.48 (-1.49%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Syndicate
Golden Entertainment files to sell 6.5M shares of common stock for holders »

J.P. Morgan and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:18
01/16/18
01/16
16:18
01/16/18
16:18
Hot Stocks
Breaking Hot Stocks news story on A10 Networks »

A10 Networks down 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
A10 Networks reports preliminary Q4 adjusted EPS 5c-6c, consensus 3c »

Reports preliminary Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMT

Core Molding

$20.85

-0.49 (-2.30%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Hot Stocks
Core Molding acquires Horizon Plastics for approximately $63M in cash »

Core Molding announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Earnings
Aerohive cuts Q4 revenue view to roughly $37M from $40M-$42M, consensus $40.89M »

The Company expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
01/16/18
01/16
16:17
01/16/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.07

3.41 (5.81%)

, UNH

UnitedHealth

$233.29

4.65 (2.03%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
General news
On The Fly: Top stock stories for Tuesday »

Stocks opened sharply…

MRK

Merck

$62.07

3.41 (5.81%)

UNH

UnitedHealth

$233.29

4.65 (2.03%)

GE

General Electric

$18.21

-0.55 (-2.93%)

NSRGY

Nestle

$86.20

1.1 (1.29%)

QCOM

Qualcomm

$68.25

2.87 (4.39%)

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

GM

General Motors

$44.19

0.12 (0.27%)

HAWK

Blackhawk

$45.08

8.575 (23.49%)

SCOR

comScore

$24.45

-4.65 (-15.98%)

UAA

Under Armour; also tag UA

$13.82

-1.305 (-8.63%)

UA

Under Armour; also tag UAA

$12.48

-1.665 (-11.78%)

NXPI

NXP Semiconductors

$119.40

-0.18 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 06

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

XON

Intrexon

$13.78

-0.935 (-6.36%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Syndicate
Intrexon files to sell common stock, no amount given »

JMP Securities LLC is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$51.85

-1.48 (-2.78%)

16:16
01/16/18
01/16
16:16
01/16/18
16:16
Hot Stocks
MetLife to merger General American Life with and into Metropolitan Tower »

MetLife announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 12

    Jun

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

, KODK

Kodak

$8.43

-0.775 (-8.42%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
Overstock's tZERO to trade KODAKCoin on future security token trading platform »

Overstock.com's…

OSTK

Overstock.com

$70.25

-8.7 (-11.02%)

KODK

Kodak

$8.43

-0.775 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:13
01/16/18
01/16
16:13
01/16/18
16:13
Hot Stocks
eHealth CFO David Francis to transition to role of Chief Operating Officer »

eHealth announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Earnings
eHealth sees FY17 adjusted EBITDA ($15.5M)-($14.5M) »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:12
01/16/18
01/16
16:12
01/16/18
16:12
Hot Stocks
eHealth acquires GoMedigap for $20M »

eHealth announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$54.06

-1.82 (-3.26%)

16:11
01/16/18
01/16
16:11
01/16/18
16:11
Earnings
Nicolet Bankshares reports Q4 EPS 88c, consensus 81c »

Reports return on average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$17.52

-0.045 (-0.26%)

16:11
01/16/18
01/16
16:11
01/16/18
16:11
Earnings
eHealth sees Q4 adjusted EBITDA ($19.3M)-($18.3M) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$37.00

-0.5 (-1.33%)

16:10
01/16/18
01/16
16:10
01/16/18
16:10
Hot Stocks
Mid Penn Bancorp, First Priority Financial Corp agree to merge »

Mid Penn Bancorp and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.